BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease

Disease outcomes are heterogeneous in Parkinson’s disease and may be predicted by gene variants. This study investigated if the BDNF rs6265 single nucleotide polymorphism (SNP) is associated with differential outcomes with specific pharmacotherapy treatment strategies in the “NIH Exploratory Trials...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurotherapeutics
Asıl Yazarlar: Fischer, D. Luke, Auinger, Peggy, Goudreau, John L., Cole-Strauss, Allyson, Kieburtz, Karl, Elm, Jordan J., Hacker, Mallory L., Charles, P. David, Lipton, Jack W., Pickut, Barbara A., Sortwell, Caryl E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851242/
https://ncbi.nlm.nih.gov/pubmed/33215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00965-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller